Plus: This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity” ...
He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...
Pharmaceutical Technology on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Culminate H Labs Co-Founders Calixto Vallejo, and Juan Carlos Rodriguez are elevating human potential through science—showing ...
New scientific methods could one day render animal studies—the standard in research laboratories for more than 100 ...
Frost & Sullivan is pleased to announce that BostonGene has been recognized for 2025 Global Technology Innovation Leadership ...
We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, ...
Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.
The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.
Asianet Newsable on MSN
OCGN stock rises pre-market after gene therapy data shows promise in rare eye disorder
Stargardt disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe ...
Mount St. Michael had 14 students competing at the showcase after being shortlisted from thousands of entries, representing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results